Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / S&P BIOTECH
-
Number of holders
-
640
-
Total 13F shares, excl. options
-
83,842,788
-
Shares change
-
-8,782,134
-
Total reported value, excl. options
-
$11,371,792,438
-
Value change
-
-$1,202,147,433
-
Put/Call ratio
-
213%
-
Number of buys
-
314
-
Number of sells
-
-239
-
Price
-
$135.65
Significant Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q1 2021
789 filings reported holding XBI - SPDR SERIES TRUST - S&P BIOTECH as of Q1 2021.
SPDR SERIES TRUST - S&P BIOTECH (XBI) has 640 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 83,842,788 shares
.
Largest 10 shareholders include MORGAN STANLEY (13,350,586 shares), GOLDMAN SACHS GROUP INC (10,956,453 shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (9,604,000 shares), BANK OF AMERICA CORP /DE/ (7,279,512 shares), JPMORGAN CHASE & CO (6,792,579 shares), BNP PARIBAS ARBITRAGE, SA (6,690,612 shares), CITIGROUP INC (6,294,958 shares), UBS Group AG (1,946,314 shares), BARCLAYS PLC (1,869,806 shares), and WELLS FARGO & COMPANY/MN (998,535 shares).
This table shows the top 640 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.